Sagimet Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:SGMT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
19 Jul 24	SellUS$43,605	George Kemble	Individual	14,062	US$3.10
19 Jul 24	SellUS$33,830	Elizabeth Rozek	Individual	10,914	US$3.10
19 Jul 24	SellUS$25,910	Eduardo Martins	Individual	8,357	US$3.10
26 Mar 24	BuyUS$63,731	David Happel	Individual	12,100	US$5.27

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SGMT?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	1,654,701	5.14%
Hedge Funds	2,393,928	7.44%
Individual Insiders	3,219,239	10%
General Public	5,492,644	17.1%
VC/PE Firms	5,573,627	17.3%
Institutions	13,861,206	43.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 40.6%.

Top Shareholders

Top 25 shareholders own 74.38% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.44%	Point72 Asset Management, L.P.	2,393,928	US$13.3m	1.18%	0.03%
6.21%	New Enterprise Associates, Inc.	2,000,275	US$11.1m	0%	0.51%
5.9%	Kleiner Perkins Caufield & Byers	1,899,475	US$10.6m	0%	2.13%
5.2%	CHI Advisors LLC	1,673,877	US$9.3m	0%	3.58%
5.14%	Jinzi Jason Wu	1,654,701	US$9.2m	0%	no data
5.14%	Ascletis Pharma Inc.	1,654,701	US$9.2m	0%	no data
4.78%	Baker Bros. Advisors LP	1,538,489	US$8.6m	-47%	0.08%
4.28%	Alyeska Investment Group, L.P.	1,378,358	US$7.7m	7.82%	0.03%
3.78%	Citadel Advisors LLC	1,215,871	US$6.8m	1.75%	0.01%
3.3%	Rushu Luo	1,062,998	US$5.9m	0%	no data
3.25%	The Vanguard Group, Inc.	1,047,540	US$5.8m	-2.48%	no data
2.96%	BlackRock, Inc.	952,591	US$5.3m	5.37%	no data
2.45%	Rock Springs Capital Management LP	787,808	US$4.4m	0%	0.13%
2.25%	Hillhouse Investment Management, Ltd.	724,800	US$4.0m	0%	0.03%
2.25%	Artal Group S.A.	724,771	US$4.0m	0%	0.11%
2.02%	PFM Health Sciences, LP	649,006	US$3.6m	0%	0.21%
1.68%	Bank of America Corporation, Asset Management Arm	540,307	US$3.0m	9.18%	no data
1.2%	Ikarian Capital, LLC	387,565	US$2.2m	-6.06%	0.55%
0.84%	Morgan Stanley, Investment Banking and Brokerage Investments	271,432	US$1.5m	-19.9%	no data
0.82%	Marshall Wace LLP	263,541	US$1.5m	0%	no data
0.8%	Dennis Hom	257,569	US$1.4m	0%	no data
0.78%	Geode Capital Management, LLC	252,298	US$1.4m	56.7%	no data
0.72%	Renaissance Technologies LLC	231,100	US$1.3m	-4.66%	no data
0.6%	Millennium Management LLC	194,153	US$1.1m	-66.3%	no data
0.59%	Duke Management Company	189,394	US$1.1m	0%	2.36%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/08 02:59
End of Day Share Price	2025/01/08 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sagimet Biosciences Inc. is covered by 8 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Andrea Tan	Goldman Sachs
Andrea Newkirk	Goldman Sachs
Antonio Arce	H.C. Wainwright & Co.